Finding New Methods to Help Testicular Cancer Patients with Surgical Recovery
A drug given to reduce the side effects of post-surgery pain medications resulting in a reduced length of hospital stay for patients who have undergone major gastrointestinal or bladder cancer procedures is found to have similar benefit for some patients undergoing surgery for testicular cancer. Rutgers Cancer Institute of New Jersey urologic oncologist Thomas Jang, MD, MPH, who is also an assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, explored the impact of alvimopan in those patients who underwent the procedure known as retroperitoneal lymph node dissection.